Acetylcysteine/Disufenton

N/A

Report date: 2022/01/24 09:16:01

Base Information

Drug NameAcetylcysteine/Disufenton

Drug Alias NameAcetylcysteine and DisufentonDisufenton/N-acetylcysteineDisufenton/acetylcysteineN-acetylcysteine and DisufentonDisufenton and N-acetylcysteine +[9]

ClassificationSmall molecules

Mechanisms of ActionFree radicals inhibitorsFree radicals scavengers

TargetsFree radicals

Therapy Area/IndicationsHearing Loss, Sensorineural

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Acetylcysteine Disufenton Sodium

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOtologic Pharmaceutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOtologic Pharmaceutics Inc

Active IndicationsN/A

Inactive IndicationsHearing Loss, Sensorineural

Other Information

ATC CodeN/A